InvestorsHub Logo
WeeZuhl
Level Icon

Followers 54
Posts 1,866
Boards Moderated 0
Alias Born 03/22/2015

WeeZuhl
Level Icon

Message
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

WeeZuhl
Level Icon

Latest Posts





I agree 100% that Hakim was attempting to use weasel wording in the PR with an intent to deceive stakeholders. Unfortunately for him, he probably relied on Dianne to write it, and she or somebody managed to screw it up by adding the word "including." They could have left that word out, and they might have an argument that what they said was technically true. Likewise, they could have left out the bit at the end about the fed study and then argued it was technically true. But when they said it was fed study and it was bioequivalent, that was an incorrect statement, and adding "including PK measures Cmax and AUC..." doesn't magically somehow make it true. It is still an absolutely incorrect statement, and when we say an incorrect thing purposefully and with an intention to deceive, well my friend, that is what we call a lie... an outright lie.

The study results demonstrated Elite’s product is bioequivalent to the branded drug based on pharmacokinetic measures including peak concentration (Cmax) and area under the curve (AUC) for opioid blood plasma levels.



.